{
    "Trade/Device Name(s)": [
        "Simplexa\u2122 Flu A/B & RSV Direct",
        "Simplexa\u2122 Flu A/B & RSV Positive Control Pack"
    ],
    "Submitter Information": "Focus Diagnostics, Inc.",
    "510(k) Number": "K152408",
    "Predicate Device Reference 510(k) Number(s)": [
        "K142365"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OOI"
    ],
    "Summary Letter Date": "August 24, 2015",
    "Summary Letter Received Date": "August 25, 2015",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A virus",
        "Influenza B virus",
        "Respiratory syncytial virus (RSV)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "3M Integrated Cycler"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time RT-PCR",
        "Direct amplification"
    ],
    "Methodologies": [
        "Molecular detection",
        "RT-PCR",
        "Multiplex nucleic acid amplification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "System",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Simplexa\u2122 Flu A/B & RSV Direct assay and Positive Control Pack for qualitative detection and differentiation of influenza A, influenza B, and RSV RNA from nasopharyngeal swabs using RT-PCR on the 3M Integrated Cycler.",
    "Indications for Use Summary": "Intended for in vitro qualitative detection and differentiation of influenza A, influenza B, and RSV RNA in nasopharyngeal swabs from patients with respiratory tract infection signs and symptoms, as an aid in differential diagnosis, used with the 3M Integrated Cycler; not for influenza C detection.",
    "fda_folder": "Microbiology"
}